**Author details**

John Hallsten and Wickii T. Vigneswaran\* Department of Thoracic and Cardiovascular Surgery, Loyola University Health System, Maywood, IL, USA

\*Address all correspondence to: wickii.vigneswaran@lumc.edu

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**121**

*Cytokine Biomarkers as Indicators of Primary Graft Dysfunction, Acute Rejection, and Chronic…*

formulation for the standardization of nomenclature in the diagnosis of lung rejection. The Journal of Heart and Lung Transplantation.

[8] Baigrie RJ, Lamont PM, Kwiatkowski D, Dallman MJ, Morris PJ. Systemic cytokine response after major surgery.

[9] Bharat A, Kuo E, Steward N, et al. Immunological link between primary graft dysfunction and chronic lung allograft rejection. The Annals of Thoracic Surgery. 2008;**86**:7

[10] Mal H, Dehoux M, Sleiman C, et al. Early release of proinflammatory cytokines after lung transplantation.

[11] Mathur A, Baz M, Staples ED, et al. Cytokine profile after lung transplantation: Correlation with allograft injury. The Annals of Thoracic

[12] Shah RJ, Diamond JM, Lederer DJ, et al. Plasma monocyte chemotactic protein-1 levels at 24 hours are a biomarker of primary graft

dysfunction after lung transplantation.

Chest. 1998;**113**:645-651

Surgery. 2006;**81**:50

Translational Research. 2012;**160**:435-442

[13] Reynaud-Gaubert M, Marin V, Thirion X, et al. Upregulation of chemokines in bronchoalveolar lavage fluid as a predictive marker of post-transplant airway obliteration. The Journal of Heart and Lung Transplantation. 2002;**21**:721-730

[14] Moreno I, Mir A, Vicente R, et al. Analysis of interleukin-6 and interleukin-8 in lung transplantation:

Correlation with nitric oxide administration. Transplantation Proceedings. 2008;**40**:3082-3084

The British Journal of Surgery.

2007;**26**:1229-1242

1992;**79**:757-760

*DOI: http://dx.doi.org/10.5772/intechopen.84661*

[1] Yusen RD, Edwards LB, Dipchand

international society for heart and lung transplantation: Thirty-third adult lung and heart-lung transplant report-2016; focus theme: Primary diagnostic indications for transplant. The Journal of Heart and Lung Transplantation.

AI, et al. The registry of the

[2] Chambers DC, Cherikh WS, Goldfarb SB, et al. The international thoracic organ transplant registry of the international society for heart and lung transplantation: Thirty-fifth adult lung and heart-lung transplant report-2018; focus theme: Multiorgan transplantation.

The Journal of Heart and Lung Transplantation. 2018;**37**:1169-1183

[3] de Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia-reperfusioninduced lung injury. American Journal of Respiratory and Critical Care Medicine. 2003;**167**:490-511

[4] Huang HJ, Yusen RD, Meyers BF, et al. Late primary graft dysfunction after lung transplantation and bronchiolitis obliterans syndrome. American Journal of Transplantation.

[5] Sundaresan S, Alevy YG, Steward N, et al. Cytokine gene transcripts for tumor necrosis factor-alpha, interleukin-2, and interferon-gamma in human pulmonary allografts. The Journal of Heart and Lung Transplantation. 1995;**14**:512-518

[6] Greenland JR, Jones KD, Hays SR, et al. Association of largeairway lymphocytic bronchitis with bronchiolitis obliterans syndrome. American Journal of Respiratory and Critical Care Medicine.

[7] Stewart S, Fishbein MC, Snell GI, et al. Revision of the 1996 working

2008;**8**:2454-2462

2013;**187**:417-423

**References**

2016;**35**:1170-1184

*Cytokine Biomarkers as Indicators of Primary Graft Dysfunction, Acute Rejection, and Chronic… DOI: http://dx.doi.org/10.5772/intechopen.84661*
